Methapharm Competitors and Similar CompaniesClear all

Methapharm's competitors and similar companies include Hikma Pharmaceuticals, Torrent Pharmaceuticals and Divis Laboratories.

	Methapharm Methapharm is a pharmaceutical company.	Hikma Pharmaceuticals Hikma focuses on a wide range of generic, branded generic and in licensed pharmaceutical products.	Torrent Pharmaceuticals Manufactures wide range of pharmaceutical products.	Divis Laboratories Divis Laboratories focussed on developing new processes for the production of Active Pharma Ingredients (APIs) & Intermediates.
Founding Date	Founding Date 1996	Founding Date 1978	Founding Date 1971	Founding Date 1990
Type	Type Private	Type Public	Type Public	Type Public
Tags	Tags Healthcare pharma	Tags Healthcare pharma	Tags Healthcare pharma	Tags Healthcare pharma
Locations	Locations Brantford, CA HQ Mississauga, CA Limassol, CY Coral Springs, US	Locations London, GB HQ Staoueli, DZ Mississauga, CA Boulogne Billancourt, FR Martinsried, DE Pavia, IT Amman, JO see more	Locations Ahmedabad, IN HQ São Paulo, BR Nürnberg, DE 32 No Market, IN Bengaluru, IN Chennai, IN Dahej, IN see more	Locations Hyderabad, IN HQ Choutuppal, IN Thondangi, IN Visakhapatnam, IN Basel, CH Basel, CH Florham Park, US
Employees	Employees 645% increase	Employees 9,500	Employees 15,718	Employees 7,9267% increase
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $3.3b (FY, 2025)	Revenue (est.) ₹137.5b (FY, 2026)	Revenue (est.) ₹105.6b (FY, 2026)
Cost of goods	Cost of goods N/A	Cost of goods $1.7b (FY, 2025)	Cost of goods ₹33.9b (FY, 2026)	Cost of goods ₹40.9b (FY, 2026)
Gross profit	Gross profit N/A	Gross profit $1.7b (FY, 2025)	Gross profit ₹105b (FY, 2026)	Gross profit ₹69.7b (FY, 2026)
Net income	Net income N/A	Net income $407m (FY, 2025)	Net income ₹21.4b (FY, 2026)	Net income ₹25.7b (FY, 2026)